Hypothesis to be tested: """"""""Serum dehydroepiandrosterone sulfate (DHEAS) of adrenal origin serves as an important precursor for ovarian steroidogenesis"""""""". If serum DHEAS is an important precursor for ovarian steroidogenesis, the hypothesis explains the need for adrenarche and for adrenal secretion of DHEAS, and it provides a rationale for a multitude of other data suggesting an undiscovered mechanism of adrenal-ovarian interaction. This hypothesis will be tested in the human using both in vivo and in vitro experiments. The in vivo experiments will include intravenous infusions of 3H-DHEAS along with either 14C-estrone or 14C-testosterone and intravenous infusions of non-isotopic DHEAS. The fractions of androstenedione, testosterone, estrone, and 17Beta-estradiol arising from serum DHEAS will be measured both in the untreated state and following pretreatment with human menopausal gonadotropins (HMG) in normal controls, women with hypothalamic amenorrhea (HA), women with polycystic ovarian disease (PCOD), and women with PCOD during dexamethasone adrenal suppression in an efficient experimental design utilizing each woman as her own control. Radioimmunoassay of DHEAS, androstenedione, testosterone, estrone, and 17Beta-estradiol will be utilized for evaluation of the results of the non-isotopic DHEAS infusions and in vitro incubations of ovarian compartments with non-isotopic DHEAS. The metabolic clearance rates (MCR) for DHEAS and testosterone will be measured simultaneously with determination of the conversion of DHEAS to testosterone for both the left and the right ovary using samples of ovarian venous blood obtained at surgery. The MCR for DHEAS and conversions of DHEAS to testosterone and estrone will be determined for the first time in non-pregnant women of reproductive age with evaluation of the effect of increases in the plasma DHEAS concentration on the MCR for DHEAS. The in vitro studies will include: 1) direct tracer assays of the conversion of DHEAS to dehydroepiandrosterone (DHEA) in cell-free preparations, and 2) analysis of the conversion of non-isotopic DHEAS to androstenedione, testosterone, estrone, and 17Beta-estradiol in cultures of ovarian compartments. One and two-way analysis of variance will be utilized for statistical analysis of the results of these investigations. This hypothesis is pertinent to understanding the medical conditions of HA and PCOD which are important causes of infertility and amenorrhea, and this information may potentially open new avenues for treating these conditions.

Project Start
1986-01-01
Project End
1989-06-30
Budget Start
1987-07-01
Budget End
1988-06-30
Support Year
2
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Women and Infants Hospital-Rhode Island
Department
Type
DUNS #
069851913
City
Providence
State
RI
Country
United States
Zip Code
02905
Haning Jr, R V; Hackett, R J; Flood, C A et al. (1993) Plasma dehydroepiandrosterone sulfate serves as a prehormone for 48% of follicular fluid testosterone during treatment with menotropins. J Clin Endocrinol Metab 76:1301-7
Haning Jr, R V; Hackett, R J; Flood, C A et al. (1993) Testosterone, a follicular regulator: key to anovulation. J Clin Endocrinol Metab 77:710-5
Haning Jr, R V; Hackett, R J; Canick, J A (1992) Steroid sulfatase in the human ovary and placenta: enzyme kinetics and phosphate inhibition. J Steroid Biochem Mol Biol 41:161-5
Haning Jr, R V; Carlson, I H; Flood, C A et al. (1991) Metabolism of dehydroepiandrosterone sulfate (DS) in normal women and women with high DS concentrations. J Clin Endocrinol Metab 73:1210-5
Haning Jr, R V; Flood, C A; Hackett, R J et al. (1991) Metabolic clearance rate of dehydroepiandrosterone sulfate, its metabolism to testosterone, and its intrafollicular metabolism to dehydroepiandrosterone, androstenedione, testosterone, and dihydrotestosterone in vivo. J Clin Endocrinol Metab 72:1088-95
Haning Jr, R V; Hackett, R J; Boothroid, R I et al. (1990) Steroid sulphatase activity in the human ovarian corpus luteum, stroma, and follicle: comparison to activity in other tissues and the placenta. J Steroid Biochem 36:175-9
Haning Jr, R V; Chabot, M; Flood, C A et al. (1989) Metabolic clearance rate (MCR) of dehydroepiandrosterone sulfate (DS), its metabolism to dehydroepiandrosterone, androstenedione, testosterone, and dihydrotestosterone, and the effect of increased plasma DS concentration on DS MCR in normal women. J Clin Endocrinol Metab 69:1047-52